These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 30464888)
1. Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle. Eid BG J Microsc Ultrastruct; 2018; 6(4):171-176. PubMed ID: 30464888 [TBL] [Abstract][Full Text] [Related]
2. Role of Cannabinoid Signaling in Cardiovascular Function and Ischemic Injury. Rorabaugh BR; Guindon J; Morgan DJ J Pharmacol Exp Ther; 2023 Dec; 387(3):265-276. PubMed ID: 37739804 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular actions of cannabinoids and their generation during shock. Wagner JA; Varga K; Kunos G J Mol Med (Berl); 1998; 76(12):824-36. PubMed ID: 9846953 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873 [TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids, blood pressure and the human heart. Sarzani R J Neuroendocrinol; 2008 May; 20 Suppl 1():58-62. PubMed ID: 18426501 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoid system as a potential target for drug development in the treatment of cardiovascular disease. Mendizábal VE; Adler-Graschinsky E Curr Vasc Pharmacol; 2003 Oct; 1(3):301-13. PubMed ID: 15320476 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in the Cardiovascular System. Ho WSV; Kelly MEM Adv Pharmacol; 2017; 80():329-366. PubMed ID: 28826540 [TBL] [Abstract][Full Text] [Related]
12. Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors. Oz M; Al Kury L; Keun-Hang SY; Mahgoub M; Galadari S Eur J Pharmacol; 2014 May; 731():100-5. PubMed ID: 24642359 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue? De Luca MA; Fattore L Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective. Perin P; Mabou Tagne A; Enrico P; Marino F; Cosentino M; Pizzala R; Boselli C Front Neurol; 2020; 11():505995. PubMed ID: 33329293 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling. Hiley CR; Ford WR Biol Rev Camb Philos Soc; 2004 Feb; 79(1):187-205. PubMed ID: 15005177 [TBL] [Abstract][Full Text] [Related]
17. Cannabis and cannabinoids: pharmacology and rationale for clinical use. Pertwee RG Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions. Mendizábal VE; Adler-Graschinsky E Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170 [TBL] [Abstract][Full Text] [Related]